scholarly journals Sexual Function and Associated Factors in Postmenopausal Women

Author(s):  
Socorro Rejany Sales Silva Trento ◽  
Alberto Madeiro ◽  
Andréa Cronemberger Rufino

Abstract Objective To assess the sexual function and associated factors in postmenopausal women. Methods This a descriptive, cross-sectional study with 380 women aged 40 to 65 years, users of public health services in 2019. Questionnaires were applied on demographic characteristics, on climacteric symptoms (menopause rating scale) and on sexual function (sexual quotient, female version). Bivariate and multiple analyses by logistic regression were performed, with adjusted odds ratios (ORad) and 95% confidence intervals (95%CIs). Results More than half (243/64%) of the participating women were at risk of sexual dysfunction, with lower scores in the domains of sexual desire and interest, comfort, orgasm, and satisfaction. Women with a partner (ORad 2.07; 95%CI 1.03–4.17) and those who reported sleep problems (ORad 2.72; 95%CI 1.77–4.19), depressed mood (ORad 2.03; 95%CI 1.32–3.10), sexual complaints (ORad 8.16; 95%CI 5.06–13.15), and vaginal dryness (ORad 3.44; 95%CI 2.22–5.32) showed greater chance of sexual dysfunction. Conclusion There was a high prevalence of sexual dysfunction, with the influence of conjugality and climacteric symptoms on sexual function.

2020 ◽  
Author(s):  
Neda Mohamadzade ◽  
Shahideh Jahanian Sadatmahalleh ◽  
Saeideh Ziaei ◽  
Narges Zaeemzadeh ◽  
Anoshirvan Kazemnejad

Abstract Background: Due to the decrease of estrogen levels in postmenopausal females, menopause can be associated with musculoskeletal pains. This study was designed to assess the possible association between musculoskeletal pains, serum estradiol level, and climacteric symptoms in postmenopausal women.Methods: This cross-sectional study was conducted on 307 postmenopausal females selected by convenience sampling method. Data collection procedure lasted from October 2016 to September 2018. The required data were collected using the Menopause Rating Scale (MRS), Örebro Musculoskeletal Pain Questionnaire (ÖMPQ), and a questionnaire containing personal data. The blood sample was taken to measure the estradiol level. Results: There was a direct relationship between musculoskeletal pains and menopause symptoms (p<0.001), age (p=0.03), parity (p=0.01), and BMI (p=0.03) and an indirect association between musculoskeletal pain and marriage age (p=0.009), age of first pregnancy (0.017), estradiol level (p<0.001) and education level (p=0.002). The regression analysis results showed that menopause symptoms were the strongest predictor of musculoskeletal pains among all the variables.Conclusions: The findings of the present study showed that although various parameters are associated with musculoskeletal pains, climacteric symptoms are the most important predictive parameters of musculoskeletal pains.


Author(s):  
Fateme Zahra Karimi ◽  
Leila Pourali ◽  
Elahe Hasanzadeh ◽  
Seyede Fateme Nosrati Hadiabad ◽  
Nasim Pouresmaeili ◽  
...  

Nowadays, women have a longer menopausal duration due to the worldwide dramatic life expectancy increase. Sexual dysfunction is one of the most prevalent problems during menopause that affect women`s quality of life, mental health, and interpersonal relationship. This study aimed to investigate sexual dysfunction and its contributing factors amongst married postmenopausal women. This cross-sectional study was conducted among 164 postmenopausal women who attended the menopause clinic of the academic hospitals in Mashhad during 2017-2018. Data were collected using a checklist that included demographic and reproductive information and the validated Persian version of the Female Sexual Function Index questionnaire (FSFI). The mean age of participants was 53.55±6.25 years. The mean FSFI score was 20.06±6.66, and 65.2% of women had sexual dysfunction. The most disturbed sexual domains were; desire (86%, n: 141), arousal (82.3%, n: 135), lubrication (71.3%, n: 117) and sexual satisfaction (70.1%, n: 115), respectively. The partner`s age (P=0.01), time since menopause onset (P=0.01), age at marriage (P=0.02), and frequency of sexual intercourse (P˂0.0001) had a significant relationship with sexual function. The sexual function of postmenopausal women in this study was highly deteriorated. The associated factors were; older age of the spouse, younger age at marriage, longer time since menopause onset, and lower frequency of sexual intercourse. It is important to determine perimenopausal women who are at potential risk of sexual dysfunction and consult them for preventive programs and strategies.  


Breast Care ◽  
2020 ◽  
pp. 1-7
Author(s):  
Daniel María Lubián López ◽  
Carmen Aisha Butrón Hinojo ◽  
Manuel Sánchez-Prieto ◽  
Nicolás Mendoza ◽  
Rafael Sánchez-Borrego

<b><i>Introduction:</i></b> The aim of this study was to investigate whether postmenopausal women with breast cancer (BC) on adjuvant aromatase inhibitor (AI) therapy have a higher prevalence of female sexual dysfunction (FSD). Second, the aim was to determine the quality of life (QoL) and level of anxiety depending on whether or not they are AI users. <b><i>Methods:</i></b> A prospective cross-sectional study involving 168 patients was performed. Three questionnaires were carried out: sexual functioning was evaluated with the Female Sexual Function Index (FSFI), while the EORTC QLQ-BR23 measures to study QoL in patients with BC and the State-Trait Anxiety Inventory (STAI) questionnaire (trait and status) were used to assess anxiety status in patients under treatment with AIs or not. <b><i>Results:</i></b> 47.6% (80/168) of the postmenopausal BC survivors were not sexually active (mean time after surgery: 48.6 months) despite a relatively low mean age (56.43 years). Postmenopausal AI-treated women had significantly worse sexual function as measured by the FSFI (23.40 ± 5.26 vs. 30.16 ± 2.24; <i>p</i> = 0.000). There were significant differences between both groups in all domains, except orgasm. The QoL score was 37.67 ± 7.38 in AI users versus 39.00 ± 1.44 among nonusers (<i>p</i> = 0.053). Patients under endocrine treatment also presented STAI scores significantly higher (25.83 ± 4.99 vs. 19.00 ± 7.12; <i>p</i> = 0.000). Trait anxiety was high in both groups, but this was not statistically significant. <b><i>Conclusions:</i></b> We observed a high prevalence of sexual inactivity among BC survivors regardless of AI use. Patients with AI use presented significantly higher prevalence of FSD, worse QoL, and greater anxiety.


Author(s):  
Gustavo Maximiliano Dutra da Silva ◽  
Sônia Maria Rolim Rosa Lima ◽  
Benedito Fabiano dos Reis ◽  
Carolina Furtado Macruz ◽  
Sóstenes Postigo

Abstract Objective The incidence of obesity, which is a chronic condition, has increased in recent years. The association between obesity and female sexual dysfunction remains unclear, particularly in postmenopausal women. In the present study, we evaluated whether obesity is a risk factor for sexual dysfunction in postmenopausal women. Methods This is a cross-sectional study that analyzed data from interviews of postmenopausal women at the Climacteric Outpatient Clinic from 2015 to 2018. After applying the inclusion and exclusion criteria, 221 women aged between 40 and 65 years old were selected and invited to participate in the study. Obesity was diagnosed according to body mass index (BMI). The participants were grouped into the following BMI categories: group 1, 18.5–24.9 kg/m2 (normal); group 2, 25.0–29.9 kg/m2 (overweight); and group 3, ≥30.0 kg/m2 (obese). Sexual function was assessed using the Female Sexual Function Index (FSFI) questionnaire. Cutoff points of ≥23 and ≥26.5 were adopted to define a diagnosis of female sexual dysfunction (FSD) based on the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision by the American Psychiatric Association (DSM-IV-TR). Results The desire and arousal scores were statistically higher in the normal BMI group than in the obese group (p = 0.028 and p = 0.043, respectively). The satisfaction scores were statistically higher in the normal BMI group than in the overweight and obese groups (p < 0.05). The total FSFI score statistically differed among the BMI categories (p = 0.027). Conclusion In the present study, obese and overweight postmenopausal women had higher total scores than women with normal BMI. Our results show that obese and overweight postmenopausal women had a higher index of dysfunction in desire and arousal and lower sexual satisfaction than normal-weight women.


2017 ◽  
Vol 39 (2) ◽  
pp. 106-109 ◽  
Author(s):  
Krishnankutty Sreelakshmy ◽  
Rajmohan Velayudhan ◽  
Deepak Kuriakose ◽  
Rema Nair

Abstract Introduction Female sexual dysfunction (FSD) in depression albeit common is strikingly understudied. The condition, if addressed properly, can be readily cured, improving the quality of life of the patient. Methods A consecutive sample of drug-naïve married female patients with depression was assessed. Depression was diagnosed using the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I). Depression severity was assessed using the Hamilton Depression Rating Scale (HAM-D), and sexual dysfunction, the Female Sexual Function Index (FSFI). Results Sexual dysfunction was found in 90% of the patients in our study. Patients with medical comorbidities showed a significant decrease in the desire subset of the FSFI (Mann-Whitney U=11.0, p=0.009), however there was no significant association with other subsets. Patients who expressed passive death wishes had higher scores on all indicators of sexual function and a significantly higher score in the orgasm subset of the FSFI (Mann-Whitney U=11.0, p=0.009). Conclusion The study showed a high prevalence of FSD in depressed females regardless of type and severity of depression. Depression with medical comorbidities was associated with a significant decrease in desire. Patients who expressed passive death wishes showed improved sexual function and significantly better orgasm.


Dermatology ◽  
2019 ◽  
Vol 236 (1) ◽  
pp. 37-45 ◽  
Author(s):  
Carlos Cuenca-Barrales ◽  
Alejandro Molina-Leyva

Background: Hidradenitis suppurativa (HS) has a high impact on quality of life. However, sexual health has scarcely been investigated. Objective: To describe the frequency of sexual dysfunction (SD) in women and erectile dysfunction (ED) in men with HS and to explore potential risk factors. Patients and Methods:We conducted a cross-sectional study using a crowd-sourced online questionnaire spread by the Spanish hidradenitis suppurativa patients’ association (ASENDHI). Results: In total, 393 participants answered the questionnaire. SD was found in 51% (95% CI 45–57%) of women and ED in 60% (95% CI 49–70%) of men. Factors related to SD were education status, patient’s global assessment for disease activity, numeric rating scale for pain and unpleasant odour and the absence of a stable relationship. Factors related to ED were increasing age, the presence of active lesions in the genital area and the number of areas affected by active lesions. Conclusions: There is a high prevalence of SD and ED in HS patients. Being in a stable relationship has been a protective factor of SD in women. The results suggest that sexual impairment in HS patients is due, at least in part, to disease activity, symptoms and active lesions.


2020 ◽  
Vol 2 (1) ◽  
pp. 87-92
Author(s):  
Suvarna Jyothi Kantipudi ◽  
Navina Suresh ◽  
Poornima Ayyadurai ◽  
Sathianathan Ramanathan

Background: Sexual dysfunction is common in females with schizophrenia and is attributed to multiple causes, including individual psychopathology and antipsychotics. Understanding the impact of relationship satisfaction on sexual functioning is not widely studied in schizophrenia. Women caregivers also experience sexual problems and were not studied in the past. Aim: To assess the nature and occurrence of sexual dysfunction in women with schizophrenia in comparison to caregivers of males without severe mental disorder. Methods: A cross-sectional study was conducted. A total of 30 women with schizophrenia were recruited as cases and 26 age-matched controls were recruited from female caregivers. All subjects were assessed using standardized tools such as Female Sexual Function Index (FSFI) and Relationship Assessment Scale along with sociodemographic questionnaire. Results: There was a significant difference in FSFI scores and relationship scores between women with schizophrenia and caregiver control subjects. The relationship quality was better in patients with schizophrenia when compared to caregivers unlike sexual functioning. Conclusion: Sexual functioning in women is a complex phenomenon. A holistic biopsychosocial approach is necessary to understand women’s sexual function.


2018 ◽  
Vol 6 (4) ◽  
pp. 15
Author(s):  
Alireza Shafiee Kandjani ◽  
Mohammad Reza Hosseinpour ◽  
Hossein Daneshamooz ◽  
Habib Shoja ◽  
Leila Nikniaz

Background: Sexual dysfuntion is a common complication of diabetes and its psychiatric and physical affects may obligate a huge burden compromising patients’ matrimonial, inter-personal and marital relationships. Current study is aimed to evaluate the frequency of sexual dysfunctions in type 2 diabetic women during 2015-2016 in Tabriz, Iran. Materials and Methods: Current cross-sectional study evaluated data gathered from 18-45 years of age type 2 diabetic women attending diabetes care centres of Tabriz. Sample size was estimated to be 300 and the sampling process fulfilled using cluster sampling methods according to the inclusion criteria. Female Sexual Function Index (FSFI) is used as the research tool. Descriptive data analysis were applied to achieve results using SPSS 20. Results: Non-parametric binominal tests reflects statistically significant decrease in sexual activity of the diabetic patients (p= 0.001). The probability of the catogry below the cut point was 1 which means that 100% of type 2 diabetic women suffer from sexual dysfunction. All items of sexual function are found to be below the average normal measurments. Conclusion: Type 2 diabetic women are vastly under the burden of sexual dysfunction, which affects their physical and psychological health. Current study showed the need to provide sufficient and available care services and organized education courses for diabetic women.


2019 ◽  
Vol 4 (2) ◽  

Background: Reports of prevalence rates of depression in postmenopause show inconsistent results, with some studies demonstrating an increase in depressive symptoms whereas others show a decrease or no difference. Objectives: To estimate the prevalence and define some risk factors of depression in postmenopausal women aged 45-65 years in primary health care settings in Riyadh, Saudi Arabia. Subjects and Methods: This cross-sectional study was conducted throughout the period June-August, 2018 at King Abdul Aziz Medical City-National Guard (KAMC-NG) in Riyadh, Saudi Arabia, in three large primary care centers. It included a sample of postmenopausal women who completed at least 12 months of amenorrhea and aged between 45 and 65 years. The Arabic version of PHQ-9 was utilized to detect depression and Menopausal rating scale (MRS) was used to assess the severity of menopausal symptoms. Results: The study included 300 women. The prevalence of major depressive symptoms among them was 29%. More than half (60.7%) of the respondents had moderate social support, three quarters (75%) scored mild to severe symptoms on the menopausal rating scale while 25% were asymptomatic.Women who were: unmarried (84.2%), housewives (79.2%), illiterate (83.2%), menopaused since≥10 years (87.5%), having more than five children (81.4%), underwent oophorectomy (100%), with poor social support (93.9%) and never exercised (82.4%) were more likely to report mild to severe symptoms. Also, significantly higher percentages of participants who have hypertension (81.9%), diabetes (82.1%), Dyslipedemia (88.1%) and hypothyroidism (81.4 %) experienced mild to severe menopausal symptoms, p<0.05. The degree of severity on the PHQ has strong significant (P<0.001) correlation with marital status, employment status, educational level and income. Conclusion: Depression is a relatively common disorder among postmenopausal women in Riyadh. Some sociodemographic indicators were identified. Care should be paid to this important group and further larger studies are recommended.


2020 ◽  
Vol 73 (suppl 4) ◽  
Author(s):  
Paula Renata Amorim Lessa Soares ◽  
Cinthia Gondim Pereira Calou ◽  
Samila Gomes Ribeiro ◽  
Priscila de Souza Aquino ◽  
Paulo Cesar de Almeida ◽  
...  

ABSTRACT Objectives: to assess the sexual function of pregnant women and the influence of sociodemographic, obstetric, and behavioral factors on sexual dysfunction. Methods: cross-sectional study conducted with 141 pregnant women attended by the Single Health System and 120 by one private service, totaling 261 participants. A questionnaire containing sociodemographic, obstetric, and behavioral variables was applied, as well as the Female Sexual Function Index instrument, which was used to assess sexual function. Associations between variables and sexual dysfunction were made using the chi-square test, considering a statistically significant result when p < 0.05. Results: among the participants, 32.1% had sexual dysfunction, and the variables “age”, “income” and “type of health service” had an influence on sexual dysfunction. The prevalence of pregnant women was between 21 and 30 years old (p < 0.001), with an income between 1 and 2 minimum wages (p = 0.048) and used the public health system network (p = 0.000). Conclusions: the factors associated with sexual dysfunction are “young pregnant women”, “low income” and “attended in the public health service”.


Sign in / Sign up

Export Citation Format

Share Document